hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06291779, orgStudyIdInfo id: SNUBH-GS- HBP5, secondaryIdInfos id: E-2211-792-350 (local IRB), type: OTHER, domain: Seoul National University Bundang Hospital, briefTitle: Diagnosis of Pancreatic Cancer by Purine Metabolite (Hypoxanthine, Xanthine) in Urine, statusModule overallStatus: RECRUITING, startDateStruct date: 2022-11-30, primaryCompletionDateStruct date: 2024-02-26, completionDateStruct date: 2024-05-31, studyFirstPostDateStruct date: 2024-03-04, lastUpdatePostDateStruct date: 2024-03-04, sponsorCollaboratorsModule leadSponsor name: Ho-Seong Han, class: OTHER, collaborators name: Seoul National University Bundang Hospital, descriptionModule briefSummary: * This study aim to develope a diagnostic method of pancreatic cancer by using a reagent for analyzing purine metabolite (Hypoxanthine, Xanthine) in urine.* It is safe and cost effective compare to radiologic or blood test. It can be used for initial screening test for healty population., conditionsModule conditions: Pancreas Cancer, conditions: Diagnosis, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_CONTROL, timePerspective: PROSPECTIVE, enrollmentInfo count: 120, type: ESTIMATED, armsInterventionsModule interventions name: Purine metabolite (Hypoxanthine, Xanthine) in urine by CubeBio, outcomesModule primaryOutcomes measure: Urine, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 80 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Ho-Seong Han, status: RECRUITING, city: Seongnam, state: Gyeonggi-do, country: Korea, Republic of, geoPoint lat: 37.43861, lon: 127.13778, hasResults: False
protocolSection identificationModule nctId: NCT06291766, orgStudyIdInfo id: 2022-05498-01, briefTitle: Gestational Diabetes After Gastric Bypass Surgery, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-01-01, primaryCompletionDateStruct date: 2028-12, completionDateStruct date: 2035-12, studyFirstPostDateStruct date: 2024-03-04, lastUpdatePostDateStruct date: 2024-03-04, sponsorCollaboratorsModule leadSponsor name: Region Skane, class: OTHER, descriptionModule briefSummary: The goal of this trial is to compare different means of glucose monitoring in women with gestational diabetes and a history of gastric bypass surgery.The main question it aims to answer is:How does continous glucose monitoring impact the treatment and affect pregnancy outcome in these women.Participants will be randomized to either continous glucose monitoring or regular capillary glucose measurements during the last trimester of their pregnancy. Researchers will compare the glucose measurement outcomes, the glucose lowering treatment given and pregnancy outcomes between groups., conditionsModule conditions: Diabetes, Gestational, conditions: Gastric Bypass Status for Obesity Complicating Pregnancy, Childbirth, or the Puerperium, conditions: Pregnancy in Diabetic, conditions: Blood Glucose Self Monitoring, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 120, type: ESTIMATED, armsInterventionsModule interventions name: FreeStyle Libre 2, continous glucose monitoring, outcomesModule primaryOutcomes measure: Adverse Pregnancy Outcome, secondaryOutcomes measure: Glucose values, secondaryOutcomes measure: Glucose values, secondaryOutcomes measure: Glucose values, secondaryOutcomes measure: Glucose values, secondaryOutcomes measure: Glucose values, secondaryOutcomes measure: Pharmacological treatment, secondaryOutcomes measure: Pharmacological treatment, secondaryOutcomes measure: Pharmacological treatment, secondaryOutcomes measure: Pharmacological treatment, secondaryOutcomes measure: Birthweight, secondaryOutcomes measure: Week of delivery, eligibilityModule sex: FEMALE, minimumAge: 18 Years, maximumAge: 50 Years, stdAges: ADULT, contactsLocationsModule locations facility: Region Skane, status: RECRUITING, city: Lund, zip: 221 85, country: Sweden, contacts name: Ulrika Moll, MD, PhD, role: CONTACT, geoPoint lat: 55.70584, lon: 13.19321, hasResults: False
protocolSection identificationModule nctId: NCT06291753, orgStudyIdInfo id: SL-B2023-478-01, briefTitle: Characteristics and Tumor Staging Proposal for Primary Malignant Melanoma of the Esophagus, statusModule overallStatus: COMPLETED, startDateStruct date: 2023-09-22, primaryCompletionDateStruct date: 2024-02-18, completionDateStruct date: 2024-02-18, studyFirstPostDateStruct date: 2024-03-04, lastUpdatePostDateStruct date: 2024-03-04, sponsorCollaboratorsModule leadSponsor name: Sun Yat-sen University, class: OTHER, descriptionModule briefSummary: Background: Primary malignant melanoma of the esophagus (PMME) is a malignant tumor originating from esophageal melanocytes with a poor prognosis. No international clinical guidelines or tumor staging systems have been proposed for PMME. This study aimed to analyze the clinical characteristics and treatment outcomes of patients with PMME and propose a tumor staging system in PMME.Materials and Methods: The clinical characteristics of 25 patients with PMME at our cancer center were summarized, and 21 patients were enrolled in a pooled analysis with 162 cases (extracted from 74 eligible articles in PubMed) for further survival analysis and proposal of PMME tumor staging., conditionsModule conditions: Primary Malignant Melanoma of the Esophagus, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_CROSSOVER, timePerspective: RETROSPECTIVE, enrollmentInfo count: 25, type: ACTUAL, outcomesModule primaryOutcomes measure: Overall Survival(OS), primaryOutcomes measure: Disease-free survival (DFS), eligibilityModule sex: ALL, minimumAge: 23 Years, maximumAge: 72 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Qianwen Liu, city: Guangzhou, state: Guangdong, country: China, geoPoint lat: 23.11667, lon: 113.25, hasResults: False
protocolSection identificationModule nctId: NCT06291740, orgStudyIdInfo id: MTU-EC-EM-2-008/67, secondaryIdInfos id: Faculty of Medicine, type: OTHER, domain: Thammasat University, Thailand, briefTitle: Continuous Versus Intermittent Nebulization Therapy in Acute Asthma Exacerbation at Emergency Department, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04, primaryCompletionDateStruct date: 2025-04, completionDateStruct date: 2025-05, studyFirstPostDateStruct date: 2024-03-04, lastUpdatePostDateStruct date: 2024-03-04, sponsorCollaboratorsModule leadSponsor name: Thammasat University, class: OTHER, descriptionModule briefSummary: The goal of this clinical is to compare treatment outcomes between continuous nebulization and intermittent therapy in the management of acute exacerbation of asthma in the emergency department(ED). Participants will random assign to either continuous or intermittent nebulization. In the continuous group, patients receive budesonide, fenoterol, ipratropium bromide, and normal saline continuously for an hour. In the intermittent group, the same medications are administer every 20 minutes for an hour. Measurements include symptom severity, respiratory rate, oxygen saturation, and pulmonary function tests. Primary endpoints are ED stay length, hospital admission, and ED revisit within 48 hours post-discharge. Adverse events are documented., conditionsModule conditions: Asthma Exacerbation, conditions: Emergency Department, conditions: Nebulization, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: randomized controlled trial (RCT), primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 40, type: ESTIMATED, armsInterventionsModule interventions name: continuous nebulization, interventions name: Intermittent nebulization, outcomesModule primaryOutcomes measure: Length of ED stay, secondaryOutcomes measure: pulmonary function test, otherOutcomes measure: Hospital admission, otherOutcomes measure: ED revisit within 48 hours, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06291727, orgStudyIdInfo id: Prisma Upstate, briefTitle: Mepivacaine vs Bupivacaine Spinal Anesthesia for TKA, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-02-16, primaryCompletionDateStruct date: 2025-07-01, completionDateStruct date: 2025-07-01, studyFirstPostDateStruct date: 2024-03-04, lastUpdatePostDateStruct date: 2024-03-04, sponsorCollaboratorsModule leadSponsor name: Prisma Health-Upstate, class: OTHER, descriptionModule briefSummary: This study is a prospective, double-blind prospective randomized controlled trial comparing mepivacaine and bupivacaine spinal anesthesia for same-day discharge readiness following a unilateral primary elective TKA procedure.Study data will be collected during the patient's hospital stay for their TKA procedure, and the primary outcome of same-day discharge readiness will be assessed the day of surgery. Patients will also be contacted at Day 3 post-op to assess for any complications, current level of pain, and pain medication utilization., conditionsModule conditions: Anesthesia, Spinal, conditions: Arthroplasty, Replacement, Knee, designModule studyType: INTERVENTIONAL, phases: PHASE4, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Patients will be randomized 1:1 to one of two groups; one receiving Mepivacaine spinal anesthesia and the other receiving Bupivacaine spinal anesthesia for total knee arthroplasty (TKA)., primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, maskingDescription: Investigators and participants will not know which anesthetic agent they receive. Anesthesia providers will be aware in order to provide correct randomization., whoMasked: PARTICIPANT, whoMasked: INVESTIGATOR, enrollmentInfo count: 138, type: ESTIMATED, armsInterventionsModule interventions name: Mepivacaine, interventions name: Bupivacaine, outcomesModule primaryOutcomes measure: Same day discharge rate, secondaryOutcomes measure: Post-operative pain score as assessed by numeric rating scale (NRS), secondaryOutcomes measure: Urinary retention as assessed by time at which patient can voluntarily void bladder post-operatively, secondaryOutcomes measure: Return of sensory and motor function as assessed by ability of patient to plantar and dorsiflex lower extremity, secondaryOutcomes measure: Post-operative nausea and vomiting as assessed by clinical documentation of nausea and vomiting post-operatively, secondaryOutcomes measure: Pain Medications as evaluated by medical morphine equivalents, secondaryOutcomes measure: Patient satisfaction levels as assessed by a 5-item Likert response scale, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Prisma Health Patewood Hospital, status: RECRUITING, city: Greenville, state: South Carolina, zip: 29615, country: United States, contacts name: Kyle Adams, role: CONTACT, phone: 864-455-3449, email: Kyle.Adams@prismahealth.org, geoPoint lat: 34.85262, lon: -82.39401, hasResults: False
protocolSection identificationModule nctId: NCT06291701, orgStudyIdInfo id: ODUSBFFTR-ELIFAYGUNPOLAT-002, briefTitle: The Relationship Between Scapular Endurance, Core Endurance, and Functional Performance in Adolescent Tennis Players, statusModule overallStatus: ACTIVE_NOT_RECRUITING, startDateStruct date: 2024-03-15, primaryCompletionDateStruct date: 2024-04-01, completionDateStruct date: 2024-04-15, studyFirstPostDateStruct date: 2024-03-04, lastUpdatePostDateStruct date: 2024-04-04, sponsorCollaboratorsModule leadSponsor name: T.C. ORDU ÜNİVERSİTESİ, class: OTHER, descriptionModule briefSummary: This study aims to examine the relationship between scapular endurance, core endurance, and upper extremity performance in adolescent tennis players. The hypothesis of this study is that better scapular/core endurance in adolescent tennis players is associated with better upper extremity performance. Establishing this relationship will contribute to identifying the exercise training necessary to improve upper extremity performance in tennis players., conditionsModule conditions: Athletic Injuries, conditions: Sports Physical Therapy, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_ONLY, timePerspective: CROSS_SECTIONAL, enrollmentInfo count: 35, type: ESTIMATED, armsInterventionsModule interventions name: Assessment of scapular endurance, interventions name: Prone Bridge Test, interventions name: Side Bridge Test, interventions name: Closed Kinetic Chain Upper Extremity Stability Test, interventions name: Seated Medicine Ball Throw Test, outcomesModule primaryOutcomes measure: Prone Bridge Test, primaryOutcomes measure: Side Bridge Test, primaryOutcomes measure: Scapular Endurance Values, primaryOutcomes measure: Closed Kinetic Chain Upper Extremity Stability Test, primaryOutcomes measure: Seated Medicine Ball Throw Test, eligibilityModule sex: ALL, minimumAge: 11 Years, maximumAge: 18 Years, stdAges: CHILD, stdAges: ADULT, contactsLocationsModule locations facility: Ordu University, city: Ordu, zip: 52200, country: Turkey, geoPoint lat: 40.97782, lon: 37.89047, hasResults: False
protocolSection identificationModule nctId: NCT06291662, orgStudyIdInfo id: PRECISE_IC, briefTitle: Evaluation of Performance Characteristics and Applicability in Oncology of Devices Customized Medical Devices Made by 3D Printing, statusModule overallStatus: RECRUITING, startDateStruct date: 2021-01-01, primaryCompletionDateStruct date: 2024-12-31, completionDateStruct date: 2025-06-30, studyFirstPostDateStruct date: 2024-03-04, lastUpdatePostDateStruct date: 2024-03-04, sponsorCollaboratorsModule leadSponsor name: Kathleen McGreevy, class: OTHER, descriptionModule briefSummary: Technologies 3D are demonstrating enormous potential for innovation in the field of surgery,introducing the concept of "treatment customization" (from planning surgery to implant design and manufacturing) on the patient's anatomy, simply by taking advantage of the patient's own common diagnostic images and the flexibility of 3D printing. In fact, this new construction technology allows the construction of the complex anatomical geometries with economy, simplicity and on scales of production unattainable by other traditional technologies. This new construction technology allows, in fact, the construction of complex anatomical geometries with economy, simplicity and on scales of production unattainable by other traditional technologies., conditionsModule conditions: Sarcoma, conditions: Intracranial Neoplasm, conditions: Pelvic Bone Neoplasm, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NON_RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Oncologic patients, primaryPurpose: OTHER, maskingInfo masking: NONE, enrollmentInfo count: 12, type: ESTIMATED, armsInterventionsModule interventions name: 3D printer applications, outcomesModule primaryOutcomes measure: 3D model feasibility for pre-surgical making decisions, primaryOutcomes measure: Surgical time, primaryOutcomes measure: Device feasibility, eligibilityModule sex: ALL, minimumAge: 7 Years, maximumAge: 70 Years, stdAges: CHILD, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Azienda Ospedaliero-Universitaria Careggi (AOUC), status: ACTIVE_NOT_RECRUITING, city: Firenze, country: Italy, geoPoint lat: 43.77925, lon: 11.24626, locations facility: Meyer Children's Hospital IRCCS, status: RECRUITING, city: Firenze, country: Italy, contacts name: Federico Mussa, MD, role: CONTACT, email: federico.mussa@meyer.it, geoPoint lat: 43.77925, lon: 11.24626, locations facility: Azienda Ospedaliero Universitaria Senese (AOUS), status: ACTIVE_NOT_RECRUITING, city: Siena, country: Italy, geoPoint lat: 43.31822, lon: 11.33064, hasResults: False
protocolSection identificationModule nctId: NCT06291636, orgStudyIdInfo id: R.24.01.2451, briefTitle: Re- Admission Rate Among Survived Patients With Acute Respiratory Failure, statusModule overallStatus: COMPLETED, startDateStruct date: 2023-01-01, primaryCompletionDateStruct date: 2023-12-31, completionDateStruct date: 2024-01-20, studyFirstPostDateStruct date: 2024-03-04, lastUpdatePostDateStruct date: 2024-03-04, sponsorCollaboratorsModule leadSponsor name: Mansoura University, class: OTHER, descriptionModule briefSummary: Readmission to the intensive care unit (ICU) results in increased consumption of medical resources and costs, and has been proposed as a marker for quality of care. ICU readmission rates have been estimated at 4 to 14% and different risk factors have been proposed by various studies Readmitted patients mostly carry poor prognosis compared to newly admitted ones, in addition to the bad psychological impact for both patient and his family, conditionsModule conditions: Respiratory Failure, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: RETROSPECTIVE, enrollmentInfo count: 994, type: ACTUAL, outcomesModule primaryOutcomes measure: Length of hospital and ICU stay and Cause of readmission, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Tamer Awad Elsayed, city: Mansoura, state: Dakhlia, zip: 050, country: Egypt, geoPoint lat: 31.03637, lon: 31.38069, hasResults: False
protocolSection identificationModule nctId: NCT06291623, orgStudyIdInfo id: Molecular Analysis, briefTitle: Molecular Analysis of Intracanal Microbes After Chemomechanical Procedure and Root Canal Medication: Clinical Study, statusModule overallStatus: COMPLETED, startDateStruct date: 2022-05-03, primaryCompletionDateStruct date: 2023-12-20, completionDateStruct date: 2024-01-15, studyFirstPostDateStruct date: 2024-03-04, lastUpdatePostDateStruct date: 2024-03-04, sponsorCollaboratorsModule leadSponsor name: Mansoura University, class: OTHER, descriptionModule briefSummary: This study aimed to evaluate clinically the intracanal microbes at molecular level after using established root canal medicament Calcium hydroxide and potential root canal medicament Glycyrrhizin.and Decontamination Analysis of Controls samples., conditionsModule conditions: Bacterial Viability of Necrotic Pulp With Asymptomatic Apical Periodontitis, designModule studyType: INTERVENTIONAL, phases: PHASE1, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: SINGLE, whoMasked: PARTICIPANT, enrollmentInfo count: 20, type: ACTUAL, armsInterventionsModule interventions name: Glycyrrhizin, outcomesModule primaryOutcomes measure: minimizing of viable bacteria which showed by Real time PCR, eligibilityModule sex: ALL, minimumAge: 19 Years, maximumAge: 60 Years, stdAges: ADULT, contactsLocationsModule locations facility: Mansoura University, city: Mansoura, state: Dakahliya, zip: 35511, country: Egypt, geoPoint lat: 31.03637, lon: 31.38069, hasResults: False
protocolSection identificationModule nctId: NCT06291610, orgStudyIdInfo id: Aarhus University Hospital, briefTitle: Feasibility Testing a Decision-support Intervention for Clinical Trials, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-02-19, primaryCompletionDateStruct date: 2025-12-31, completionDateStruct date: 2026-12-31, studyFirstPostDateStruct date: 2024-03-04, lastUpdatePostDateStruct date: 2024-03-04, sponsorCollaboratorsModule leadSponsor name: University of Aarhus, class: OTHER, descriptionModule briefSummary: A decision-support intervention are developed for a Danish nationwide randomised controlled trial (RCT) among patients with laryngeal and pharyngeal cancer referred to curative intended radiotherapy. The primary endpoints in this RCT are levels of dysphagia and xerostomia.The decision-support intervention consists of three components, including (1) a patient decision aid tailored to clinical trial participation and (2) decision coaching consultations carried out by trained healthcare professionals. Finally, (3) a training program in decision coaching will be an integrated part of the intervention.To feasibility test (beta test) the intervention, 60 patient participants will be included, separated into pre- (n=30) and post- (n=30) intervention groups. Pre-intervention to complete the survey based on current clinical practice. Post-intervention to complete the survey following engagement in the decision support intervention.A total of 12 physicians will be recruited and trained in decision coaching. To assess the acceptability of the intervention, the physicians will be interviewed. Additionally, they will be asked to audio-record two decision coaching sessions to test the fidelity of the intervention., conditionsModule conditions: Head and Neck Neoplasms, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, interventionModelDescription: Pre- and post-intervention measures in two consecutive groups., primaryPurpose: HEALTH_SERVICES_RESEARCH, maskingInfo masking: NONE, maskingDescription: Patients are recruited anonymous, enrollmentInfo count: 60, type: ESTIMATED, armsInterventionsModule interventions name: Clinical trial decision support intervention, outcomesModule primaryOutcomes measure: Decisional conflict scale, primaryOutcomes measure: The decision preparation scale, secondaryOutcomes measure: The stages of decision making measure, secondaryOutcomes measure: Items on health literacy, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Aarhus University Hospital, status: RECRUITING, city: Aarhus, zip: 8200, country: Denmark, contacts name: Anne Kristensen, role: CONTACT, phone: +4530315605, email: annkrs@rm.dk, contacts name: Cai Grau, role: CONTACT, email: cai.grau@rm.dk, geoPoint lat: 56.15674, lon: 10.21076, hasResults: False